Sequence analysis of EBV DNA isolated from mouth washings and PBMCs of healthy individuals and blood of EBV-LPD patients

Journal of Clinical Virology

Volumn 28, Issue 1, 2003, Pages 85-92

  Van Kooij, B ^a   Thijsen, S F T ^a   Meijer, E ^a   Niesters, H G M ^b   Van Esser, J W J ^b   Cornelissen, J J ^b   Verdonck, L F ^a   Van Loon, A M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

DNA; Epstein Barr virus; LMP 1 gene; Lymphoproliferative disorder; Polymerase chain reaction; Sequence analysis

Indexed keywords

LATENT MEMBRANE PROTEIN 1;

ADULT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; DNA EXTRACTION; DNA ISOLATION; EPSTEIN BARR VIRUS; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MONONUCLEAR CELL; MOUTH HYGIENE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS REACTIVATION; VIRUS STRAIN;

ADULT; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; LEUKOCYTE TRANSFUSION; LEUKOCYTES, MONONUCLEAR; LYMPHOPROLIFERATIVE DISORDERS; MIDDLE AGED; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 0041589361     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(02)00269-X     Document Type: Article

References (17)

1. Babcock G.J., Decker L.L., Freeman R.B., Thorley-Lawson D.A. Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J. Exp. Med. 190:1999;567-576.
2. Boom R., Sol C.J.A., Salimans M.M.M., Jansen C.L., Wertheim-van Dillen P.M.E., Noordaa van der J. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 1990;495-503.
3. Cavazzana Calvo M., Bensoussan D., Jabado N., Haddad E., Yvon E., Moskwa M., et al. Prevention of EBV-induced B-lymphoproliferative disorder by ex vivo marrow B-cell depletion in HLA-phenoidentical or non-identical T-depleted BM transplantation. Br. J. Haematol. 103:1998;543-551.
4. Chang Y.S., Su I.J., Chung P.J., Shu C.H., Ng C.K., Wu S.J., et al. Detection of an Epstein-Barr-virus variant in T-cell-lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population. Int. J. Cancer. 62:1995;673-677.
5. Van Esser J.W.J., Niester H.G.M., Thijsen S.F.T., Meijer E., Osterhaus A.D.M.E., Wolthers K.C., et al. Molecular quantitation of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus associated lymphproliferative disease after allogeneic stem cell transplantation. Br. J. Haematol. 113:2001;814-821.
6. Gratama J.W., Ernberg I. Molecular epidemiology of Epstein-Barr virus infections. Adv. Cancer Res. 67:1995;197-255.
7. Gratama J.W., Oosterveer M.A., Lepoutre J.M., van Rood J.J., Zwaan F.E., Vossen J.M., et al. Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients. Transplantation. 49:1990;725-730.
8. Gratama J.W., Oosterveer M.A.P., Zwaan F.E., Lepoutre J., Klein G., Ernberg I. Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc. Natl. Acad. Sci. USA. 85:1988;8693-8696.
9. Hudson G.S., Farrell P.J., Barrell B.G. Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8. J. Virol. 53:1985;528-535.
10. Khanim F., Yao Q.Y., Niedobitek G., Sihota S., Rickinson A.B., Young L.S. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood. 88:1996;3491-3501.
11. Knecht H., Bachmann E., Joske D.J., Sahli R., Emery Goodman A., Casanova J.L., et al. Molecular analysis of the LMP (latent membrane protein) oncogene in Hodgkin's disease. Leukemia. 7:1993;580-585.
12. Knowles D.M., Cesarman E., Chadburn A., Frizzera G., Chen J., Rose E.A., et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood. 85:1995;552-565.
13. Meijer E., Slaper-Cortenbach I.C.M., Thijsen S.F.T., Dekker A.W., Verdonck L.F. Increased incidence of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation from matched unrelated donors due to a change of T-cell depletion technique. Bone Marrow Transplant. 29:(4):2002;335-339.
14. Miller W.E., Edwards R.H., Wallin D.M., Raab-Traub N. Sequence variation in the Epstein-Barr virus latent membrane protein 1. J. Gen. Virol. 72:(Pt5):1994;2729-2740.
15. Niesters H.G., van Esser J., Fries E., Wolthers K.C., Cornelissen J., Osterhaus A.D. Development of a real-time quantitative assay for detection of Epstein-Barr virus. J. Clin. Microbiol. 38:2000;712-715.
16. Sandvej K., Peh S.C., Andresen B.S., Pallesen G. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood. 84:1994;4053-4060.
17. Shapiro R.S., McClain K., Frizzera G., Gajl-Peczalska K.J., Kersey J.H., Blazar B.R., et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood. 71:(5):1988;1234-1243.